Ebola virus: A gap in drug design and discovery - experimental and computational perspective
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ebola virus: A gap in drug design and discovery - experimental and computational perspective
Authors
Keywords
-
Journal
Chemical Biology & Drug Design
Volume 89, Issue 3, Pages 297-308
Publisher
Wiley
Online
2016-09-17
DOI
10.1111/cbdd.12870
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Virtual screening of the inhibitors targeting at the viral protein 40 of Ebola virus
- (2016) V. Karthick et al. Infectious Diseases of Poverty
- Small molecule inhibitors of ebola virus infection
- (2015) Edwige Picazo et al. DRUG DISCOVERY TODAY
- Exploring interaction mechanisms of the inhibitor binding to the VP35 IID region of Ebola virus by all atom molecular dynamics simulation method
- (2015) Yan-Jun Zhang et al. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
- Ebola Virus Entry: A Curious and Complex Series of Events
- (2015) Sven Moller-Tank et al. PLoS Pathogens
- Ebola, the killer virus
- (2015) Haider Ghazanfar et al. Infectious Diseases of Poverty
- Possible FDA-approved drugs to treat Ebola virus infection
- (2015) Shu Yuan Infectious Diseases of Poverty
- Anti-Ebola Activity of Diazachrysene Small Molecules
- (2015) Života Selaković et al. ACS Infectious Diseases
- X-ray Structures of Human Furin in Complex with Competitive Inhibitors
- (2014) Sven O. Dahms et al. ACS Chemical Biology
- Ebola Vaccination: If Not Now, When?
- (2014) Alison P. Galvani et al. ANNALS OF INTERNAL MEDICINE
- Characterization of host immune responses in Ebola virus infections
- (2014) Gary Wong et al. Expert Review of Clinical Immunology
- The clinically approved drugs amiodarone, dronedarone and verapamil inhibit filovirus cell entry
- (2014) Gerrit Gehring et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Ebola virus envelope glycoprotein derived peptide in human Furin-bound state: computational studies
- (2014) I. Olaposi Omotuyi JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- In Silico Derived Small Molecules Bind the Filovirus VP35 Protein and Inhibit Its Polymerase Cofactor Activity
- (2014) Craig S. Brown et al. JOURNAL OF MOLECULAR BIOLOGY
- Elucidation of the Ebola Virus VP24 Cellular Interactome and Disruption of Virus Biology through Targeted Inhibition of Host-Cell Protein Function
- (2014) Isabel García-Dorival et al. JOURNAL OF PROTEOME RESEARCH
- A Novel Life Cycle Modeling System for Ebola Virus Shows a Genome Length-Dependent Role of VP24 in Virus Infectivity
- (2014) A. Watt et al. JOURNAL OF VIROLOGY
- Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430
- (2014) Travis K. Warren et al. NATURE
- Human Ebola virus infection in West Africa: a review of available therapeutic agents that target different steps of the life cycle of Ebola virus
- (2014) Kang Lai et al. Infectious Diseases of Poverty
- Structural Rearrangement of Ebola Virus VP40 Begets Multiple Functions in the Virus Life Cycle
- (2013) Zachary A. Bornholdt et al. CELL
- Could the Ebola virus matrix protein VP40 be a drug target?
- (2013) Robert V Stahelin EXPERT OPINION ON THERAPEUTIC TARGETS
- The Ebola Virus Matrix Protein Penetrates into the Plasma Membrane
- (2013) Emmanuel Adu-Gyamfi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Multiple Cationic Amphiphiles Induce a Niemann-Pick C Phenotype and Inhibit Ebola Virus Entry and Infection
- (2013) Charles J. Shoemaker et al. PLoS One
- A Systematic Screen of FDA-Approved Drugs for Inhibitors of Biological Threat Agents
- (2013) Peter B. Madrid et al. PLoS One
- FDA-Approved Selective Estrogen Receptor Modulators Inhibit Ebola Virus Infection
- (2013) L. M. Johansen et al. Science Translational Medicine
- Filovirus entry into cells – new insights
- (2012) Emily Happy Miller et al. Current Opinion in Virology
- Ebolavirus VP35 suppresses IFN production from conventional but not plasmacytoid dendritic cells
- (2011) Lawrence W Leung et al. IMMUNOLOGY AND CELL BIOLOGY
- Recombinant Vesicular Stomatitis Virus–Based Vaccines Against Ebola and Marburg Virus Infections
- (2011) Thomas W. Geisbert et al. JOURNAL OF INFECTIOUS DISEASES
- Ebola virus entry requires the cholesterol transporter Niemann–Pick C1
- (2011) Jan E. Carette et al. NATURE
- Biochemical and Structural Characterization of Cathepsin L-Processed Ebola Virus Glycoprotein: Implications for Viral Entry and Immunogenicity
- (2010) C. L. Hood et al. JOURNAL OF VIROLOGY
- Oligomerization of Ebola Virus VP40 Is Essential for Particle Morphogenesis and Regulation of Viral Transcription
- (2010) T. Hoenen et al. JOURNAL OF VIROLOGY
- The Tyro3 Receptor Kinase Axl Enhances Macropinocytosis of Zaire Ebolavirus
- (2010) C. L. Hunt et al. JOURNAL OF VIROLOGY
- Ebola haemorrhagic fever
- (2010) Heinz Feldmann et al. LANCET
- Advanced antisense therapies for postexposure protection against lethal filovirus infections
- (2010) Travis K Warren et al. NATURE MEDICINE
- Ebola virus uses clathrin-mediated endocytosis as an entry pathway
- (2010) Suchita Bhattacharyya et al. VIROLOGY
- Cellular Entry of Ebola Virus Involves Uptake by a Macropinocytosis-Like Mechanism and Subsequent Trafficking through Early and Late Endosomes
- (2010) Mohammad F. Saeed et al. PLoS Pathogens
- Interaction between Ebola Virus Glycoprotein and Host Toll-Like Receptor 4 Leads to Induction of Proinflammatory Cytokines and SOCS1
- (2009) A. Okumura et al. JOURNAL OF VIROLOGY
- Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor
- (2008) Jeffrey E. Lee et al. NATURE
- Ebolavirus and Marburgvirus: Insight the Filoviridae family
- (2007) Paolo Ascenzi et al. MOLECULAR ASPECTS OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search